Aster DM Quality Care Aug 5 call for Q1 results

Conference call scheduled for 5 August

Aster DM Quality Care Limited has scheduled an earnings conference call with analysts and investors for Wednesday, 5 August 2026. The call is set for 6:00 PM IST and will focus on the company’s unaudited financial results for the quarter ended 30 June 2026. Such calls are typically used to walk investors through headline numbers and provide management commentary on operating performance. For market participants, the timing is relevant because it helps set expectations around reported results and near-term business priorities. The company has indicated that registration for the call is available through its official investor portal.

What management will discuss

The stated agenda is the unaudited financial results for the quarter ended 30 June 2026. The company has not provided additional items beyond the results discussion in the provided details. Investors generally track revenue, operating profitability, and net profit trends across quarters, especially for hospital operators where occupancy, case mix, and cost controls can influence margins. Any clarification around quarter-on-quarter (QoQ) and year-on-year (YoY) movements in operating metrics is typically central to these interactions.

Key details: date, time, topic, registration

The call details disclosed by the company include the date, time, topic, and the registration channel. The company has pointed participants to its investor portal for registration access. This is important for investors who want to join live and access any supporting materials shared by the company.

Corporate change: name update effective July 28, 2026

Aster DM Healthcare Limited is set to rename itself as Aster DM Quality Care Limited with effect from July 28, 2026, as stated in the provided information. For investors, a name change can matter operationally because it affects how the company appears in disclosures and communications. It also becomes relevant for tracking continuity of financial reporting across periods. The call on 5 August 2026 is therefore positioned shortly after the stated effective date of the name change.

Snapshot of reported financial metrics (as provided)

Alongside the call announcement, the provided text contains several financial metrics stated in ₹ crore, including QoQ and YoY comparisons. The figures below are reproduced as stated, without inferring the reporting period beyond what is explicitly provided.

Quarterly table excerpt included in the data

The provided content also includes a quarterly table titled “Quarterly - Aster DM Healthcare Q1 Results” with values for fiscal periods including Jun 25 and Mar 26, with QoQ and YoY comparisons. In that table, Total Revenue is shown at ₹1,182.38 crore for Mar 26 and ₹1,077.87 crore for Jun 25. Net Income Before Taxes is shown at ₹163.35 crore for Mar 26 and ₹136.44 crore for Jun 25. Diluted Normalized EPS is shown at 2.70 for Mar 26 and 1.73 for Jun 25. These figures may be referenced by investors for trend analysis across quarters and versus the prior-year period presented in the same table.

Additional performance highlights mentioned

The provided text also lists performance highlights for multiple periods. For Q1 FY26, revenue is stated at ₹1,078 crore, up 8% YoY versus ₹1,002 crore in Q1 FY25. Operating EBITDA for Q1 FY26 is stated at ₹215 crore, up 21% YoY versus ₹177 crore in Q1 FY25, with an operating EBITDA margin of 20.0% versus 17.7% last year. Normalised PAT (Post NCI) for Q1 FY26 is stated at ₹90 crore, up 22% YoY versus ₹74 crore in Q1 FY25, excluding one-time merger-related costs as stated.

For Q2 FY26, revenue is stated at ₹1,197 crore, up 10% YoY and 11% QoQ. Operating EBITDA is stated at ₹263 crore, up 13% YoY and 22% QoQ, with operating EBITDA margins at 22.0% versus 21.4% in Q2 FY25 and 20.0% in Q1 FY26. Normalised PAT (Post NCI) is stated at ₹110 crore, up 14% YoY and 23% QoQ.

Dividend and earnings calendar items noted

The data also includes corporate action references. It states that Aster DM Quality Care Ltd. declared a dividend of ₹3.00 on 02 Apr, 2026. Separately, it states the upcoming earnings date for Aster DM Quality Care Ltd. as 30th Apr, 2026. These items are presented in the text as part of the broader results and corporate action information.

Market impact: what investors are likely to watch

The immediate market relevance is the scheduled opportunity to hear management’s discussion of the unaudited quarter ended 30 June 2026. Investors typically focus on the relationship between revenue movement and operating profit expansion. In the figures provided, operating profit of ₹224.05 crore is presented with a strong QoQ increase of 28.61% and YoY growth of 43.95%, while revenue of ₹1,182.38 crore is presented with a marginal QoQ decline of 0.29%. This combination usually prompts questions around cost structure, utilisation, and mix, although no additional explanation is included in the provided information.

Conclusion

Aster DM Quality Care’s 5 August 2026 earnings conference call at 6:00 PM IST is positioned as the main forum to discuss unaudited results for the quarter ended 30 June 2026, with access via the investor portal. The call also follows the stated name change effective July 28, 2026. Investors will use the interaction to reconcile the reported profitability and revenue trends cited in the provided figures with the company’s broader quarterly performance disclosures.